ViVest, founded in 2019, is a pioneering medical company dedicated to the prevention, monitoring, and treatment of ventricular arrhythmias, as well as providing advanced cardiac rhythm data services.

Our mission is to deliver comprehensive, innovative solutions that enhance the prevention, monitoring, treatment, and rehabilitation of ventricular arrhythmias worldwide. In February 2025, we proudly received MDR (Medical Device Regulation) approval for our X Series Automated External Defibrillator (AED). Our products are now available in multiple countries across Europe, Asia Pacific, Latin America, and the Middle East/Africa.

As the first company in China to independently develop wearable cardiac defibrillator(WCDs), ViVest is committed to innovation in cardiac health. In recognition of the critical clinical need for such products, ViVest continues to lead the way in improving the prevention and treatment of Sudden Cardiac Death (SCD) both inside and outside hospitals.

ViVest remains dedicated to technological innovation with our core mission: “Focusing on Technological Innovation, Caring for Heart Health.” Looking ahead, we aim to develop the world’s first multi-parameter Sudden Cardiac Death Risk Assessment System, integrating wearable products for ventricular arrhythmias and remote data service management. This system will revolutionize the treatment of Sudden Cardiac Death, shifting the approach from passive response to precise, proactive management of ventricular arrhythmia, combining prevention and treatment seamlessly.